BioInterface 2014 Agenda

Event Endorsed by the Society for Biomaterials

Monday | Tuesday | Wednesday

Keynote | BioInterface Home

Monday, October 6

BioInterface Workshop:

"From Entrepreneur to CEO: The Path from an Idea to a Product”

Co-Chairs: Kristen Cardinal, Cal Poly-San Luis Obispo; Janelle Gunther, Janssen Global Services, LLC; Mikki Larner, Plasma Technology Systems, LLC 

7:45 – 8:45am
Pre-Registration and Continental Breakfast
8:45 – 9:00am

Welcome and Introduction

9:00 – 9:45am

Duncan Maitland, Texas A&M University
"Embolic Applications of Shape Memory Polymer Foams: Commercialization In Progress"

9:45 – 10:30am

Kate Garrett, Ciel Medical
"The Biodesign Process & BronchoGuard Case Study"

10:30 – 10:45am


10:45 – 11:30am  

Vic McCray, Ocular Dynamics
“The Enemy of Good is Better:  Rapid Iteration in Medical Device Development”

11:30am – 12:15pm

Casey McGlynn Wilson Sonsini Goodrich & Rosati
"Insights on Early Stage Funding" 

12:15 – 1:15pm


1:15 – 2:00pm

Leslie Field, Stanford University
"IP and Marketing on the Path to Commercialization: Protecting and Communicating Your Product's Unique Value"

2:00 – 2:45pm

Kirk Zeller, SI-BONE, Inc.
"International Market Entry Strategies for Medical Device Start-ups: Which Markets and Why?"

2:45 – 3:00pm
3:00 – 4:00pm

Applied Technology Workshops (30-minutes each)

Chair: Josh Simon 

Presentations by: Christensen Fonder P.A., CSIRO, DSM Biomedical, Inc., and Microscopy Innovations, LLC

4:00 – 4:30pm
Opening Reception
4:30 – 5:30pm

Keynote Lecture: Kevin Edward Healy, Ph.D.

Jan Fandrianto, Distinguished Professor in Engineering at the University of California at Berkeley in the Departments of Bioengineering and Materials Science and Engineering


Kevin E. Healy, Ph.DKevin E. Healy, Ph.D. is the Jan Fandrianto Distinguished Professor in Engineering at the University of California at Berkeley in the Departments of Bioengineering and Materials Science and Engineering. He also serves as Chair of the Department of Bioengineering. He received a B.Sc. in Chemical Engineering from the University of Rochester in 1983. He obtained graduate degrees in Bioengineering from the University of Pennsylvania (M.Sc. 1985, Ph.D. 1990).
His research interests include the design and synthesis of bioinspired materials that actively direct the fate of stem cells, and facilitate regeneration of damaged tissues and organs. Major discoveries from his laboratory have centered on the control of cell fate and tissue formation in contract with materials that are tunable in both their biological content and mechanical properties. These materials find applications in medicine, dentistry, and biotechnology. Prof. Healy has authored or co-authored more than 350 published articles, abstracts, or book chapters. He recently co-edited a multi-volume scholarly reference work on the biomaterials field, containing an all-encompassing comprehensive treatise that accurately captures the diversity, breadth, and dimensions of the field.

Dr. Healy is an elected Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and the American Association for the Advancement of Science (AAAS). He has chaired the Gordon Research Conference on Biomaterials and Biocompatibility, and has been honored with the 2011 Clemson award for outstanding contributions to basic biomaterials science. He is a named inventor on numerous issued United States and international patents relating to biomaterials, therapeutics, and medical devices, and has founded several companies to develop these systems for applications in biotechnology and regenerative medicine. He is currently an Associate Editor of the Journal of Biomedical Materials Research. He has served on numerous panels and grant review study sections for N.I.H. and international scientific agencies. He has given more than 250 invited lectures in the fields of Biomedical Engineering and Biomaterials.

Back to the Top >>

Tuesday, October 7

7:30 – 8:30am
Registration and Continental Breakfast 
President’s Welcome
8:30 – 10:00am

Session 1: Characterization Methods

Chair: Bill Theilacker, Medtronic

8:30 – 9:00am

Invited Speaker: Ian Gilmore, National Physical Laboratory
"Advances in Mass Spectrometry Imaging”

9:00 – 10:00am

Lara Gamble, University of Washington
“ToF-SIMS Iimaging Investigation of Tumor Micro Environments”

Norman Munroe, Florida International University
“Surface Responses of Ti Alloys for Orthopedic Implant Materials After Anodization Technique”       
Katarzyna Wygladacz, Bausch + Lomb
Physical, Surface, and Durability Properties Studies of a Silicone Hydrogel Material Designed with Two-Phase Polymerization Processing

10:00 – 10:30am
Exhibitor Break
10:30am – 12:00pm

Session 2: Recent Developments in Materials and Coatings

Chair: Norman Munroe, Florida International University

10:30 – 11:00am

Invited Speaker:  Nik de Bont, DSM Biomedical  
“Low-particulate ComfortCoat® Coating Allows Ease of Movement of Angioplasty Devices”

11:00am – 12:00pm

Norman Munroe, Florida International University
“Surface Characteristics of Modified Biomaterials and their Biocompatibility"

Laurence Meagher, CSIRO Materials Science Engineering
Coatings for the Culture of Stem and Progenitor Cells on 2D and 3D

Mehdi Golozar, University of Cambridge
"Extending the Application of Plasma Electrolytic Oxide Coatings to Novel Low-rigidity β-Ti Alloys: Applications to Load-bearing Orthopaedic Implants

12:00 – 1:00pm
Attendee Luncheon & Student Town Hall Meeting
1:00 – 1:30pm
Surfaces in Biomaterials Foundation Annual Business Meeting
1:30 – 3:00pm

Session 3: Recent Developments in Ophthalmology

Co-Chairs: Andrew Luk, CooperVision and James Parakka, DSM Biomedical

1:30 – 2:00pm

Invited Speaker:  Lynn Winterton; Better Vision Group, LLC
“Material Innovation Leading to Comfortable Contact Lenses – Can a Contact Lens Really be More Comfortable than No Lens at All?”

2:00 – 3:00pm

Tejal A. Desai, University of California, San Francisco
“Nanostructured Thin Films for Ocular Drug Delivery”

Aylvin Dias, DSM Biomedical
“Amino Acid Based Biodegradable Polyesteramides for Drug Delivery

Jeffrey Linhardt, Google
“New Developments in Contact Lenses: Optimizing Surface, Design, andMoving Toward Smart Contact Lenses”

3:00 – 4:00pm

Reception Featuring:
The Academic Poster Competition and Industrial Poster Presentations

4:00 – 5:00pm

Session 4: Point Counterpoint Debate

Back to the Top >>

Free Time to Explore the Area

Wednesday, October 8

8:00 – 8:30am
Registration and Continental Breakfast
8:30 – 10:00am       

Session 5: Surface Modification for Improved Hemocompatibility

Chair: Dave Sogard, American Medical Systems

8:30 – 9:00am  

Invited Speaker:  Melissa M. Reynolds, Colorado State University
Metal Organic Frameworks as Mix-ins for Improved Hemocompatibility”

9:00 – 10:00am

Chelsea M. Kirschner, Sharklet Technologies, Inc.
“Bio-inspired Microtopographies Reduce Thrombosis on Blood-Contacting Materials”
Joseph McGonigle, SurModics, Inc. 
“Surface Modification of Medical Devices With Fully Synthetic Coatings For Improved Hemocompatibility”

Bernke Papenburg, MATERIOMICS B.V.                   
Designing Surfaces to Gain Improved Medical Device Functionality”

10:00 – 10:45am
Exhibitor Break & Poster Session   
10:45am – 12:15pm

Sesssion 6: Cell response at Nano BioInterface

Chair: Dimitrios Zeugolis, National university of Ireland – Galway

10:45 – 11:15am

Invited Speaker:  Prof Michael Sailor; UCSD
Harnessing Silicon Nanomaterials for Medicine”

11:15am – 12:15pm

Manus Biggs, National University of Ireland, Galway
“Cellular Adhesion on Electron-beam Patterned Surfaces Presenting Nanoscale Heterogeneous Rigidity”

Peter Loskill, University of California, Berkeley
Unraveling the Impact of Subsurface and Surface Properties on the Adhesion of Bacterial Cells

Robert S. Kellar, Development Engineering Sciences, LLC
Nanofiber Tropoelastin Provides Unique Material Properties for theBiointerface”

12:15 - 1:30pm        

Awards Luncheon:
Student Poster Winner Announcement

Excellence in Surface Science Award Presentation: From Beginning to Commercialization: What's Involved
2014 Recipient: Thomas J. Fogarty, Fogarty Engineering & the Institute for Innovation

Dr. Thomas J. Fogarty is an internationally recognized cardiovascular surgeon, inventor, entrepreneur, and vintner. He has been involved with a wide spectrum of innovations in business and technology. Dr. Fogarty has served as founder/co-founder, and Chairman/Board Member of over 33 various business and research companies, based on medical devices designed and developed by Fogarty Engineering, Inc. During the past 40 years, he has acquired 135 surgical patents, including the “industry standard” Fogarty balloon catheter and the widely used Aneurx Stent Graft that replaces open surgery aortic aneurysm. Dr. Fogarty has received countless awards and honors; most significantly, he is the recipient of the Jacobson Innovation Award of the American College of Surgeons and the 2000 Lemelson-MIT prize for Invention and Innovation, and was inducted into the Inventors Hall of Fame and the National Academy of Engineering.

Recently, Dr. Fogarty and his colleagues founded the Fogarty Institute for Innovation at El Camino Hospital. The purpose of the Institute is to create an environment where innovation in medicine is encouraged, supported, and nurtured.

Dr. Fogarty received his undergraduate education at Xavier University in Ohio and his medical degree from the University of Cincinnati. He completed his residency at the University of Oregon and later served as Medical Staff President at Stanford Medical Center, 1973-1975. After 13 years directing the Cardiovascular Surgery Program at Sequoia Hospital, Redwood City, California, he returned to academic life at Stanford University School of Medicine in July 1993 as Professor of Surgery. Dr. Fogarty now spends his time creating new medical devices with Fogarty Engineering and the Institute for Innovation.

1:30 – 3:00pm

Session 7: Anti-Infective Medical Device Technologies

Chair: Janelle Gunther, Janssen Global Serices, LLC

1:30 – 2:00pm

Invited Speaker: Vu L. Truong, Aridis Pharmaceuticals
“Gallium-Siderophore Complexes as Anti-Infectives: Synthesis, Gallium Complexation, and Bacterial Inhibition by Siderophore-Based Gallium Compounds”

2:00 – 3:00pm

Robert Ward, ExThera Medical Corporation
“Removal of Drug-Resistant Bacteria from Whole Blood with a Sorbent
Hemoperfusion Device: Carbapenem-Resistant Enterobacteriaceae
(‘CRE Superbugs’)

Ethan E. Mann, Sharklet Technologies, Inc.
“Microtopographies Limit Bacterial Biofilm Accumulation: A Novel
Approach to Decreasing Ventilator-Associated Pneumonia Cases”

Ryan Looper, Curza
Medical Device Technologies: Potential to Treat and Prevent Biofilm Implant-Related Infections”

3:00 – 3:15pm
3:15 – 4:45pm        

Session 8: Technologies and Recent Progress: Percutaneous Heart Valves

Chair: Itai Pelled, Edwards LifeSciences Israel

Sponsor: Edwards LifeSciences

3:15 – 3:45pm

Invited Speaker: Stanton Rowe, Edwards LifeSciences
“Development History of the First Percutaneous Aortic Valve”

3:45 – 4:45pm

William Fearon, Stanford University
“TAVR – the Clinician Point of View”

Crystal Cunanan, Boston Scientific
“Development of a Second Generation TAVI Valve—LOTUS’”

Aruna Perera, Direct Flow Medical, Inc.
“Direct Flow Medical Trans Catheter Aortic Valve Replacement”


BioInterface 2014 Program Concludes

Back to the Top >>

Membership Software Powered by YourMembership  ::  Legal